As part of its continued commitment to providing high-quality information to professionals in the pharmaceutical industry, Springer has acquired the prestigious journal Advances in Therapy, to be published from 2008. With this move, Springer further enhances its services for clients in the pharmaceutical, healthcare and biotechnology industries.
Advances in Therapy, to be published by Springer Healthcare Communications (SHC), will continue to publish original research from the academic and research community across the globe as well as drug reviews and commissioned articles. Now in its 24th year of publication, the journal is Medline Indexed and has a strong Impact Factor, listed in both the ISI subject categories Pharmacology and Pharmacy and Medicine, Research and Experimental. The first issue of Advances in Therapy published by SHC will be Volume 25, No. 1, 2008.
The key feature of Advances in Therapy is the rapid publication of original research. Continuing this practice, SHC will increase its already rapid publication times to ensure online availability through SpringerLink within six weeks of submission. From 2008, Advances in Therapy will double its publication frequency from bimonthly to monthly.
Stephen Entwistle, Vice President of SHC, said, Advances in Therapy works closely with pharmaceutical researchers to deliver clinically important results to the academic and industrial community. I am very proud that the journal is now part of the Springer family and I am confident that the journals inclusion on SpringerLink will speed dissemination of important research worldwide.
|Contact: Renate Bayaz|